Research Program Leaders

More than 300 members, representing 42 University departments, are working together to improve the understanding of cancer and to develop new lifesaving procedures in cancer prevention, diagnosis, and treatment. UPMC Hillman Cancer Center CCSG research programs range from basic science programs that examine the molecular basis of cancer development and progression in the laboratory, to translational and clinical programs that implement novel laboratory findings into clinical trials in humans, to population-based programs that focus on cancer prevention, epidemiology, and biobehavioral factors in cancer.

Research Program Leaders

• Kathryn Schmitz, PhD, MPH
  Interim Director and Associate Director for Population Sciences
• José P. Zevallos, MD MPH
  Interim Deputy Director
• Dana Bovbjerg, PhD
  Co-Leader, Biobehavioral Cancer Control Program
• Marci Lee Nilsen, PhD, MSN, RN, CHPN, FAAN
  Co-Leader, Biobehavioral Cancer Control Program
• Adam Brufsky, MD, PhD
  Co-Leader, Cancer Therapeutics Program
• Ronald Buckanovich, MD, PhD
  Co-Leader, Cancer Biology Program
• Greg Delgoffe, PhD
  Co-Leader, Cancer Immunology and Immunotherapy Program
• Shou-Jiang (SJ) Gao, PhD
  Co-Leader, Cancer Virology Program
• Haitao Guo, PhD
  Co-Leader, Cancer Virology Program
• James Herman, MD
  Co-Leader, Cancer Epidemiology and Prevention Program
• Steffi Oesterreich, PhD
  Co-Leader, Cancer Biology Program
• Patricia Opresko, PhD
  Co-Leader, Genome Stability Program
• Roderick O’Sullivan, PhD
  Co-Leader, Genome Stability Program
• Peter Wipf, PhD
  Co-Leader, Cancer Therapeutics Program
• Jian-Min Yuan, MD, PhD
  Co-Leader, Cancer Epidemiology and Prevention Program
• Hassane Zarour, MD
  Co-Leader, Cancer Immunology and Immunotherapy Program